AXT, Inc. (AXTI) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong demand for indium phosphide, a record backlog, and plans for capacity expansion, which are positive indicators. Although there are challenges with export permits, management is optimistic about resolving them. The financial performance shows improved margins and reduced losses, and the potential for revenue growth is high. The Q&A session reveals confidence in meeting demand and expanding customer traction. Overall, despite some uncertainties, the company's outlook and strategic initiatives are likely to positively impact the stock price.
Key Financial Performance
Revenue $23.0 million in Q4 2025, compared to $28.0 million in Q3 2025 and $25.1 million in Q4 2024. The decline year-over-year is attributed to lower export permits and geopolitical complexities.
Indium Phosphide Revenue $8.0 million in Q4 2025, primarily from data center applications. No year-over-year comparison provided.
Gallium Arsenide Revenue $7.0 million in Q4 2025. No year-over-year comparison provided.
Germanium Substrates Revenue $231,000 in Q4 2025. No year-over-year comparison provided.
Raw Material Joint Venture Revenue $7.6 million in Q4 2025. No year-over-year comparison provided.
Non-GAAP Gross Margin 21.5% in Q4 2025, compared to 22.6% in Q3 2025 and 18.0% in Q4 2024. The year-over-year improvement is due to better manufacturing efficiencies.
GAAP Gross Margin 20.9% in Q4 2025, compared to 22.3% in Q3 2025 and 17.6% in Q4 2024. The year-over-year improvement is due to better manufacturing efficiencies.
Non-GAAP Operating Expense $7.8 million in Q4 2025, compared to $6.5 million in Q3 2025 and $9.8 million in Q4 2024. The year-over-year decrease is due to cost control measures.
GAAP Operating Expense $8.8 million in Q4 2025, compared to $7.3 million in Q3 2025 and $10.6 million in Q4 2024. The year-over-year decrease is due to cost control measures.
Non-GAAP Operating Loss $2.6 million in Q4 2025, compared to $384,000 in Q3 2025 and $5.4 million in Q4 2024. The year-over-year improvement is due to better cost management and improved gross margins.
GAAP Operating Loss $3.8 million in Q4 2025, compared to $1.1 million in Q3 2025 and $6.2 million in Q4 2024. The year-over-year improvement is due to better cost management and improved gross margins.
Non-GAAP Net Loss $2.6 million or $0.06 per share in Q4 2025, compared to $1.2 million or $0.02 per share in Q3 2025 and $4.2 million or $0.10 per share in Q4 2024. The year-over-year improvement is due to better cost management and improved gross margins.
GAAP Net Loss $3.6 million or $0.08 per share in Q4 2025, compared to $1.9 million or $0.04 per share in Q3 2025 and $5.1 million or $0.12 per share in Q4 2024. The year-over-year improvement is due to better cost management and improved gross margins.
Cash, Cash Equivalents, and Investments $128.4 million as of December 31, 2025, an increase of $97.2 million from Q3 2025, primarily due to a public offering of common stock.
Accounts Receivable Decreased by $2.6 million in Q4 2025. No year-over-year comparison provided.
Depreciation and Amortization $2.3 million in Q4 2025. No year-over-year comparison provided.
Stock Compensation $1.3 million in Q4 2025. No year-over-year comparison provided.
Net Inventory Increased by $4 million to $81.7 million in Q4 2025. No year-over-year comparison provided.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Indium Phosphide Wafers: Backlog reached over $60 million, driven by AI and data center build-outs. Expanded customer base includes Tier 1 laser manufacturers and optical transceiver module makers globally. Capacity increased by 25% since October 2025, with plans to double by the end of 2026.
Gallium Arsenide: Demand for semi-insulating wafers for wireless RF devices and VCSEL lasers for autonomous vehicles and robotics is growing, particularly in China.
Raw Material Business: Growth in Q4 driven by PBN crucibles and high-quality indium refining, ensuring supply chain control for indium phosphide substrates.
Geographic Demand: Strong demand in the U.S. for AI and data center upgrades. Rapid growth in China for data center expansion and AI capabilities, with revenue expected to grow by over 60% in Q1 2026.
Export Permits: Delays in Q4 impacted growth, but permits received in Q1 2026 improved the position. Export licenses remain a critical factor for growth.
Operational Efficiency: Focus on gross margin improvement, OpEx discipline, and inventory reduction to drive profitability.
IPO of Tongmei in China: Plans to list subsidiary Tongmei on the STAR Market in Shanghai remain active, driven by AI infrastructure build-out in China.
Capacity Expansion: Significant investment in 6-inch indium phosphide products to meet next-generation device requirements.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Export Permits: The company faced challenges in obtaining export permits in Q4 2025, which significantly impacted their ability to meet revenue expectations. The timing and success of obtaining these permits remain unpredictable and are a critical factor for future growth.
Revenue Decline: Revenue decreased from $28.0 million in Q3 2025 to $23.0 million in Q4 2025, reflecting operational and market challenges.
Operating Loss: The company reported a non-GAAP operating loss of $2.6 million in Q4 2025, a significant increase from the $384,000 loss in Q3 2025, indicating rising operational inefficiencies.
Geopolitical Risks: Geopolitical complexities, particularly related to export permits and the company's operations in China, pose significant risks to business continuity and growth.
Inventory Management: Net inventory increased by approximately $4 million in Q4 2025, highlighting potential inefficiencies in inventory management and the need for better control.
Regulatory and Environmental Risks: Increased environmental regulations in China and the need to comply with regulatory requirements for export permits add operational and compliance challenges.
Customer Concentration: The top 5 customers accounted for 22.6% of total revenue, indicating a reliance on a limited customer base, which could pose risks if any major customer reduces orders.
Supply Chain Dependencies: The globalized and complex supply chain for optical transceivers creates dependencies and potential vulnerabilities, especially in the context of geopolitical tensions.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Expectations: Sequential growth in revenue is expected in Q1 2026, primarily driven by growth in indium phosphide for data center build-out for AI. Revenue related to the data center market in China is expected to grow by more than 60% in Q1 over Q4 2025.
Market Trends: The massive AI infrastructure build-out and planned CapEx spending by cloud services and AI platform providers in the United States are primary drivers for EML and silicon photonic-based optical transceivers. In China, the data center build-out is early in its ramp but experiencing rapid growth.
Capacity Expansion: AXT has added approximately 25% more capacity since October 2025 and plans to double its capacity from Q4 2025 levels by the end of 2026. A major focus will be on increased investment in 6-inch indium phosphide products.
Customer Base Expansion: AXT is expanding its customer base for indium phosphide, including Tier 1 laser manufacturers and optical transceiver module makers globally. Backlog for indium phosphide wafers has reached a new high of over $60 million.
Export Permits: The receipt of indium phosphide and gallium arsenide export licenses remains a significant factor for growth. Approximately $26 million in revenue is expected in Q1 2026 from orders with existing permits or those not requiring permits. Additional upside is possible if more permits are received.
Profitability Outlook: AXT expects a non-GAAP net loss in Q1 2026 in the range of $0.02 to $0.04 per share and a GAAP net loss in the range of $0.04 to $0.06 per share, representing progress towards profitability.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you clarify the revenue number for the quarter?
A:The management confirmed a revenue number of '26 and expressed confidence in achieving it. They mentioned the possibility of exceeding this number if more permits are obtained, but no specific higher number was provided.
Q:What insights do you have on the licensing process and any rejected permits?
A:The licensing process is described as non-transparent with significant variability. Initially, it was a 60-business-day process, but now it varies. Some permits have been denied with instructions to resubmit with more information. Management is optimistic about these denials as they see them as fixable and potentially impactful for Q1 numbers.
Q:Can you provide details on the backlog and customer demand forecasts?
A:The backlog increased from $49 million to over $60 million. Customers are ordering further out, with some providing forecasts beyond 2030. Demand is growing weekly, and customers are giving longer lead times to support capacity expansion. Backlog is influenced by permit dynamics, with a 6-month window to export after receiving a permit.
Q:What are the plans for capacity additions and associated costs?
A:Capacity is expected to double by the end of 2026, requiring approximately $30 million for the first phase using existing facilities. Beyond 2026, another doubling is planned for 2027, with costs estimated between $100 million and $150 million for greenfield expansion.
Q:What is the revenue capacity and demand outlook for indium phosphide?
A:Revenue capacity is projected to reach $35 million per quarter by the end of the year. Management is confident in meeting this demand, contingent on obtaining permits. Growth is driven by both domestic and international demand, particularly from AI-related applications.
Q:What is the status of customer traction and 6-inch indium phosphide development?
A:Management is gaining traction with new and existing customers, including Tier 1 customers. There is significant interest in 6-inch indium phosphide, and capacity expansion plans include scaling up 6-inch production alongside 3-inch and 4-inch wafers.
Q:What would unrestricted demand or shipments look like in Q4?
A:Unrestricted by permits, the company could manufacture and ship all demand, which exceeds current manufacturing capacity. By the end of the year, capacity is expected to reach $35 million per quarter.
Q:What are the gross margin expectations with increased shipments and larger wafer sizes?
A:Gross margins are expected to approach 35% with increased shipments. Larger wafer sizes, such as 4-inch and 6-inch, generally offer better margins, though 6-inch is still in the development stage and may initially have lower margins.
Q:Review of Unclear Management Responses
A:Management avoided providing a specific higher revenue number beyond '26, despite discussing the potential to exceed it. Additionally, the licensing process was described as non-transparent, and no clear reasons were provided for permit denials. The response to unrestricted demand was also vague, focusing on manufacturing capability without quantifying potential revenue.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI capability
AI expansion
AI infrastructure
AXT history
China ability
China automobile
China center
Dr Young
EML silicon
Tier
VCSEL
VCSELs
VP
backlog
build AI
case
center build
crucible
demand indium
discussion
driver
end
expansion customer
infrastructure build
laser application
moment
phosphide center
phosphide substrate
phosphide wafer
plan capacity
point
quality
receipt
requirement
scale application
silicon photonic
term
timing
transceiver
AXTI Transcript
AXT, Inc. (AXTI) Q1 2026 Earnings Call Transcript
Unknown4-30
Despite future growth projections and strategic initiatives like the China subsidiary listing, the company's current financial performance shows a decline in revenue, gross margin, and net income. Risks related to global economic conditions and export permits further exacerbate concerns. The lack of clarity in the Q&A session suggests management's uncertainty, impacting investor confidence. Overall, the negative financial results and operational risks outweigh the optimistic projections, leading to a negative sentiment.
AXT, Inc. (AXTI) Q4 2025 Earnings Call Transcript
Positive2-20
The earnings call highlights strong demand for indium phosphide, a record backlog, and plans for capacity expansion, which are positive indicators. Although there are challenges with export permits, management is optimistic about resolving them. The financial performance shows improved margins and reduced losses, and the potential for revenue growth is high. The Q&A session reveals confidence in meeting demand and expanding customer traction. Overall, despite some uncertainties, the company's outlook and strategic initiatives are likely to positively impact the stock price.
AXT, Inc. (AXTI) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call indicates strong growth in indium phosphide revenue, driven by global demand, particularly outside China. Despite a non-GAAP loss, the company is optimistic about improving gross margins and expanding capacity. The backlog for indium phosphide has more than doubled, and customer interest is high due to product quality. The Q&A session revealed positive analyst sentiment and confidence in future growth. However, the company's cash position has decreased, and some management responses lacked clarity. Overall, the positive growth outlook and strong demand outweigh the financial concerns, suggesting a positive stock price reaction.
AXT, Inc. (AXTI) Q2 2025 Earnings Call Transcript
Unknown7-31
The earnings call summary shows mixed signals: improvements in gross margins and operating expenses are positive, but ongoing losses and cash depletion are concerning. The Q&A reveals potential growth in indium phosphide demand, but uncertainties in export licenses and permitting delays pose risks. The company's optimistic guidance and backlog could boost stock, but lack of clarity on license issues tempers this optimism. The absence of a market cap makes it hard to predict volatility, but overall, the sentiment is balanced, leading to a neutral stock price prediction.
AXTI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
